{"id":958871,"date":"2026-11-10T03:04:09","date_gmt":"2026-11-10T03:04:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/958871\/"},"modified":"2026-11-10T03:04:09","modified_gmt":"2026-11-10T03:04:09","slug":"australian-developed-mnd-therapy-advances-to-phase-2-clinical-trial","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/958871\/","title":{"rendered":"Australian-developed MND therapy advances to Phase 2 clinical trial"},"content":{"rendered":"<p>An Australian-developed therapy aimed at halting motor neurone disease progression and restoring function will advance to a national Phase 2 clinical trial.<\/p>\n<p>The 75-participant trial follows encouraging earlier trial results developed from research at The University of Queensland&#8217;s Queensland Brain Institute (QBI) and advanced by clinical-stage biotechnology company NuNerve.<\/p>\n<p>NuNerve was established by UQ&#8217;s commercialization company, UniQuest, and the Estate Peter Goodenough Unit Trust to advance more than 25 years of research originating at QBI by Emeritus Professors Perry Bartlett and Andrew Boyd.<\/p>\n<p>Emeritus Professor Bartlett AO and NuNerve chair said a protein-based therapy, called NUN-004, was designed to inhibit a receptor, EphA4, whose excessive signalling has been linked to motor neuron degeneration and impaired recovery of nerve connections.<\/p>\n<p>Targeting nerve repair<\/p>\n<p>Professor Bartlett said the therapy was developed to pursue a more ambitious goal than slowing decline alone.<\/p>\n<p>&#8220;No approved treatment has been shown to halt or reverse progression across the broad MND population,&#8221; he said.<\/p>\n<p>&#8220;Current treatments largely focus on slowing the loss of function.<\/p>\n<p>&#8220;NUN-004 was designed to go further to protect motor neurons and create the conditions for damaged neural connections to repair.<\/p>\n<p>&#8220;We have spent more than 25 years following the biology of EphA4, from understanding its role in motor neuron connections to developing a therapy that can now be tested rigorously in people living with MND.&#8221;<\/p>\n<p>Motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a progressive neurological condition that affects the nerve cells in the brain and spinal cord responsible for movement.<\/p>\n<p>As these motor neurons deteriorate and die, the brain can no longer send signals to the muscles, leading to muscle weakness, wasting, and loss of function over time.<\/p>\n<p>Discovery to clinical translation<\/p>\n<p>The trial will recruit 75 participants across 6 Australian clinical sites at the Sunshine Coast, Sydney, Newcastle, Brisbane, and Perth.<\/p>\n<p>Researchers will assess change in function, safety and tolerability, as well as respiratory, neurophysiological, quality-of-life and <a href=\"https:\/\/www.news-medical.net\/health\/What-is-a-Biomarker.aspx\" class=\"linked-term\" rel=\"nofollow noopener\" target=\"_blank\">biomarker<\/a> measures.\u00a0<\/p>\n<p>NuNerve Clinical Lead Associate Professor Antony Winkel said the study had been carefully designed to determine whether NUN-004 could meaningfully change the course of MND.<\/p>\n<p>&#13;<\/p>\n<p>This trial combines measures of everyday function with respiratory, neurophysiological and biomarker assessments to determine whether the early Phase I signal is a real treatment effect.<\/p>\n<p>&#13;<br \/>\n&#13;<\/p>\n<p>If those findings are confirmed, they would represent an important result for people living with MND and place Australian MND research firmly on the international stage.&#8221;<\/p>\n<p>&#13;<br \/>\n&#13;<\/p>\n<p style=\"text-align: right;\">Professor Antony Winkel,\u00a0NuNerve Clinical Lead Associate Professor<\/p>\n<p>&#13;<\/p>\n<p>UniQuest CEO Dr Dean Moss said progressing NUN-004 into a Phase 2 clinical trial was an important milestone in the long journey from university research to potential new treatments.<\/p>\n<p>&#8220;This is a powerful example of what research translation looks like over the long term, with more than 25 years of UQ discovery now progressing through a company created to take that science forward,&#8221; he said.<\/p>\n<p>&#8220;We&#8217;re proud of UniQuest&#8217;s role in helping establish NuNerve and supporting a pathway for this research to be rigorously tested in people living with MND.&#8221;<\/p>\n<p>Source:<\/p>\n<p><a href=\"https:\/\/news.uq.edu.au\/2026-11-national-clinical-trial-australian-developed-mnd-therapy\" rel=\"noopener nofollow\" target=\"_blank\">The University of Queensland<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"An Australian-developed therapy aimed at halting motor neurone disease progression and restoring function will advance to a national&hellip;\n","protected":false},"author":2,"featured_media":958872,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[64,63,14939,4335,1362,2287,137,58109,61927,11749,17326,1368,1543,337,4086,39080,46081],"class_list":["post-958871","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-au","tag-australia","tag-biomarker","tag-biotechnology","tag-brain","tag-clinical-trial","tag-health","tag-motor-neurone-disease","tag-motor-neurons","tag-nerve","tag-neuron","tag-neurons","tag-protein","tag-research","tag-respiratory","tag-therapy","tag-translation"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/958871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=958871"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/958871\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/958872"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=958871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=958871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=958871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}